Carcinogenicity and hormone studies with the tissue‐selective estrogen receptor modulator bazadoxifene
Authors:
- 4 September 2012
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 228 (4) , 724-733
Abstract
Bazedoxifene Acetate (BZA) is a selective estrogen receptor modulator (SERM) that is approved for the prevention and/or treatment of osteoporosis in postmenopausal women. To assess for carcinogenic potential, BZA was administered ad libitum in the diet to rats for 2 years. BZA caused an increase in benign ovarian tumors in female rats and decreased incidences of mammary tumors (females) and pituitary tumors (males and females). In addition, BZA provided a significant survival benefit at all dosages tested, which correlated with a significant reduction in pituitary and mammary gland tumors and decreased body weight gain (both genders). Additional studies were subsequently conducted in rats and monkeys to further explore the mechanisms likely responsible for the observed effects. Results from studies in hypophysectomized and chemically castrated female rats indicated that BZA did not directly stimulate formation of ovarian cysts, but an intact pituitary was required for cyst formation. Further, BZA increased estradiol concentrations in rats and monkeys. In monkeys, BZA increased concentrations of luteinizing hormone (LH) after onset of treatment and prohibited the preovulatory surge of LH until after cessation of treatment. These hormonal changes suggest that BZA inhibited both the positive and negative feedback effects of estrogen on gonadotropins and the resulting increase in LH caused formation and persistence of ovarian cysts, which eventually transformed into benign ovarian granulosa cell tumors in the rat carcinogenicity study. These results also suggest that the reductions in pituitary and mammary gland tumors were attributed to BZA-related antagonism of endogenous estrogens at the estrogen receptors. J. Cell. Physiol. 228: 724–733, 2013.Keywords
This publication has 44 references indexed in Scilit:
- Estrogen dependent signaling in reproductive tissues – A role for estrogen receptors and estrogen related receptorsMolecular and Cellular Endocrinology, 2012
- The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesisGynecologic Oncology, 2012
- The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1Molecular Pharmacology, 2011
- Elevated Luteinizing Hormone in Prepubertal Transgenic Mice Causes Hyperandrogenemia, Precocious Puberty, and Substantial Ovarian PathologyEndocrinology, 1997
- Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophsMolecular and Cellular Endocrinology, 1985
- Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levelsLife Sciences, 1983
- Damage to Hypothalamic Dopaminergic Neurons Is Associated with Development of Prolactin-Secreting Pituitary TumorsScience, 1982
- Estrogen receptor levels in estrogen sensitive cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1979
- Radioimmunoassay of rat prolactin: Prolactin levels in plasma of rats with spontaneous pituitary tumours, primary oestrone-induced pituitary tumours or pituitary tumour transplantsEuropean Journal of Cancer (1965), 1969
- Pituitary Tumors in Mice after Prolonged Feeding of Synthetic ProgestinsScience, 1966